ANDA 85088, held by Upsher Smith Labs. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 85088 (Hydralazine Hydrochloride), held by Upsher Smith Labs, was first approved by FDA on Sep 16, 1994, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride50MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
| Sep 16, 1994 | Original application | Approved | None posted |
| Nov 3, 1983 | Supplement 20Manufacturing | Approved | None posted |
| Nov 3, 1983 | Supplement 19Manufacturing | Approved | None posted |
| Apr 7, 1983 | Supplement 14Manufacturing | Approved | None posted |
| Apr 7, 1983 | Supplement 12Manufacturing | Approved | None posted |
| Apr 7, 1983 | Supplement 11Manufacturing | Approved | None posted |
| Apr 7, 1983 | Supplement 8Manufacturing | Approved | None posted |
| Feb 22, 1983 | Supplement 18Manufacturing | Approved | None posted |
| Feb 22, 1983 | Supplement 17Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters